ArticleCurrent microbiology2025
Exploring the Shared miRNA-mRNA Signature Network Between Helicobacter pylori Infection and Gastric Cancer: A Comparative Study.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer (GC) is the fifth most prevalent cancer worldwide, with Helicobacter pylori (H. pylori) infection as the leading cause. MicroRNAs (miRNAs), critical post-transcriptional regulators of gene expression, play pivotal roles in both H. pylori infection and GC pathogenesis. However, not all the dysregulated miRNAs exert a downstream effect on mRNAs, steering the pathologies. Utilising GEO datasets and literature curation, we compiled a comprehensive list of human differentially expressed (hDE) miRNAs in H. pylori-infected cell lines (HP-hDEmiRs) and GC tissues (GC-hDEmiRs). The identified targets of hDEmiRs from publicly available databases were compared with hDEmRNAs retrieved from GEO in each pathology to build a miRNA-mRNA network exhibiting inverse expression patterns, and the resultant miRNAs were considered as 'Functional hDEmiRs'. Subsequently, 24 upregulated and 10 downregulated functional HP-hDEmiRs with 57 and 18 targets and 38 upregulated and 7 downregulated functional GC-hDEmiRs with 230 and 20 targets were identified, respectively. The miRNA-mRNA network of functional GC-hDEmiRs was validated using GC-hDEmRNAs from TCGA and a shared subset of functional hDEmiRs in H. pylori infection and GC was identified. This includes the upregulated hsa-miR-98-5p, hsa-miR-21-5p, hsa-let-7c-5p, hsa-let-7f-5p, hsa-let-7i-5p, hsa-miR-15a-5p, hsa-miR-181b-5p, hsa-miR-25-3p and the downregulated hsa-miR-204-5p, that could have a combinatorial effect in H. pylori infection to GC progression. Moreover, along with the TCGA-validated hydroxyacyl-CoA dehydrogenase (HADH), the epithelial splicing regulatory protein-2 (ESRP2) and dihydrolipoamide branched chain transacylase E2 (DBT) were downregulated in both conditions, possibly attributed to the effect of functional hDEmiRs targeting them. Our findings offer potential candidates for miRNA-directed therapeutics in these pathologies.
Indexed as
Identifiers
40622415What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.